Proteon logo     Print Page | Close Window

SEC Filings

S-1
PROTEON THERAPEUTICS INC filed this Form S-1 on 09/16/2014
Entire Document
 

Table of Contents

 
  As of December 31,   As of June 30,  
 
  2012   2013   2014  
 
   
   
  (unaudited)
 
 
  (in thousands)
 

Balance Sheet Data:

                   

Cash and cash equivalents

  $ 2,409   $ 2,793   $ 8,646  

Working capital

    6,499     (4,438 )   19,915  

Total assets

    7,782     5,659     27,142  

Preferred stock

    90,286     96,405     123,904  

Common stock and additional paid-in capital

    4     4     4  

Total stockholders' deficit

    (86,656 )   (100,514 )   (109,290 )

(1)
See Note 2 within the notes to our financial statements appearing elsewhere in this prospectus for a description of the method used to calculate basic and diluted net loss per common share and pro forma basic and diluted net loss per common share.

(2)
Pro forma to reflect the conversion of our preferred stock into shares of common stock upon the closing of this offering and the extinguishment of the liability related to the Series D investors' purchase rights.

65